Literature DB >> 7542669

Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin.

J F Marshall1, D C Rutherford, A C McCartney, F Mitjans, S L Goodman, I R Hart.   

Abstract

We have shown previously that VUP was the only line out of ten human melanoma lines that failed to express the vitronectin receptor alpha v beta 3, but instead expressed alpha v beta 1. Levels of alpha v beta 1 expression were low on parental VUP cells so that iterative sorting by FACS, using an anti-alpha v antibody (13C2), was utilised to derive sublines with 8- to 10-fold higher amounts of cell surface alpha v beta 1. There was little difference between low (V-) and high (V+) alpha v beta 1-expressing sublines with regard to adherence to collagen type I, collagen type IV or laminin substrata. However, adherence to vitronectin and fibrinogen correlated closely with alpha v beta 1 expression (35-42% adhesion for V(+) lines versus 6-8% adhesion for V- lines on vitronectin, for example). Utilising a high alpha v beta 1-expressing subline (V + B2) we have shown that binding to vitronectin and fibrinogen was inhibited specifically by function-blocking antibodies to alpha v (17E6 and 14D9) and beta 1 (A11B2). V(+) sublines spread more compared with V(-) sublines on both vitronectin and fibronectin. However, neither alpha 5- nor alpha v-blocking antibodies had any effect on attachment or spreading of V + B2 on fibronectin whereas the combination of alpha 5 (PID6)- and alpha v(17E6)-blocking antibodies abrogated binding to fibronectin almost completely. This is the first report of an alpha v beta 1 integrin able to recognize vitronectin and fibrinogen, and also cooperate with alpha 5 beta 1 to mediate attachment to and spreading on fibronectin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542669     DOI: 10.1242/jcs.108.3.1227

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  18 in total

1.  Integrin alpha(v)beta1 is an adenovirus coreceptor.

Authors:  E Li; S L Brown; D G Stupack; X S Puente; D A Cheresh; G R Nemerow
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Fibronectin receptor functions in embryonic cells deficient in alpha 5 beta 1 integrin can be replaced by alpha V integrins.

Authors:  J T Yang; R O Hynes
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

3.  Integrin alpha5beta1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16.

Authors:  E Davison; R M Diaz; I R Hart; G Santis; J F Marshall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 4.  Substrates for clinical applicability of stem cells.

Authors:  Sanjar Enam; Sha Jin
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

5.  Atomic basis for the species-specific inhibition of αV integrins by monoclonal antibody 17E6 is revealed by the crystal structure of αVβ3 ectodomain-17E6 Fab complex.

Authors:  Bhuvaneshwari Mahalingam; Johannes F Van Agthoven; Jian-Ping Xiong; José Luis Alonso; Brian D Adair; Xianliang Rui; Saurabh Anand; Mehrdad Mehrbod; Mohammad R K Mofrad; Christa Burger; Simon L Goodman; M Amin Arnaout
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

6.  Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates.

Authors:  Rebecca L DiMarco; Daniel R Hunt; Ruby E Dewi; Sarah C Heilshorn
Journal:  Biomaterials       Date:  2017-03-18       Impact factor: 12.479

7.  Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus.

Authors:  Terry Jackson; A Paul Mould; Dean Sheppard; Andrew M Q King
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 8.  Mechanisms of talin-dependent integrin signaling and crosstalk.

Authors:  Mitali Das; Sujay Ithychanda; Jun Qin; Edward F Plow
Journal:  Biochim Biophys Acta       Date:  2013-07-24

9.  β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.

Authors:  W Shawn Carbonell; Michael DeLay; Arman Jahangiri; Catherine C Park; Manish K Aghi
Journal:  Cancer Res       Date:  2013-05-03       Impact factor: 12.701

10.  A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins.

Authors:  B Felding-Habermann; S Silletti; F Mei; C H Siu; P M Yip; P C Brooks; D A Cheresh; T E O'Toole; M H Ginsberg; A M Montgomery
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.